Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT04089202
Eligibility Criteria:
Inclusion Criteria:
* Male and female subjects age 18-80, inclusive
* Diagnosed with type 2 diabetes at least 6 months prior to screening
* Not previously seen within the prior three years in the endocrinology clinic for diabetes management
* Referred to endocrinology for diabetes care directly from primary care
* Willing to wear an Abbott® FreeStyle Libre Pro for 7-14 days
* English speaking
* Able and willing to complete questionnaires
Exclusion Criteria:
* Planned travel or surgery during the time of libre wear
* Patients without a diagnosis of type 2 diabetes, including individuals with type 1 diabetes and gestational diabetes
* Women referred for diabetes care during pregnancy, or while breastfeeding or who intend to become pregnant during involvement in this trial
* Currently using real time CGM or FGM system
* Concurrent involvement in another clinical trial using diabetes pharmacotherapy
* Individuals with active malignancy undergoing treatment with chemotherapy and/or high dose glucocorticoids
* Individuals with rheumatic disease undergoing treatment with high dose glucocorticoids
* Planned magnetic resonance imaging (MRI), computed tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the time of Libre wear
* Any cognitive or other disorders, in the investigator's opinion, that may interfere with participation or ability to follow the study protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04089202
Study Brief:
Protocol Section:
NCT04089202